Abstract Staff members of the Department of Pathology, University of Iowa Hospitals and Clinics set...

1
Abstract Staff members of the Department of Pathology, University of Iowa Hospitals and Clinics set forth to redesign and improve the pre-analytical and post-analytical process phases of the gynecologic cytopathology testing cycle through the utilization of process analysis tools and the application of Lean methodology. The project team developed detailed process maps and why-why tree diagrams of the reasoning for certain steps or constraints within the current process. These process analysis tools effectively served to establish a common understanding of the current process. The team was then able to thoroughly assess the current process for deviations from Lean principles and identified various sources of waste and process defects. Process redesigns were drafted and trialed for feasibility prior to implementation. The redesigns effectively reduced the total number of steps within these processes by 40% versus the number of steps being performed at project inception. The redesigns applied to gynecologic specimen receipt and accessioning processes: 1) effectively transformed the process from a batch-and-queue workflow to single piece flow, 2) eliminated a significant process constraint, and 3) provided a systematic means for reducing specimen labeling errors. The team’s assessments also identified inefficiencies in billing processes that were eliminated by process redesign. Overall, the team’s improvement project demonstrated that a process-focused analysis governed by the application of Lean principles can effectively improve laboratory operations, reduce the potential for error, and identify many other opportunities for improvements in tangential processes. Background The Cytopathology Laboratory receives and accessions roughly 18,000 gynecologic cytology specimens annually. A lack of a consensus understanding of the current workflows and the relevant “history” that lead to the current state created frustrations. Consequently, it was difficult to manage this area. Ultimately, management decided the pre and post analytical workflows of this laboratory were prime candidates for a formalized process improvement project. Methods (cont.) Phase 2: “As-is” process analysis and measurements. Process mapping the current processes. (Figures 1a,b & 2). Process maps were developed by directly observing the primary operators performing the current processes. The process maps established a baseline representation and facilitated a common understanding of the current state. Use of the “5-Whys” tool to analyze key features of the process (Figure 3) Enabled thorough analysis and effectively identified the reasoning and root causes behind the current state. Identification of process steps contrary to Lean principles. Conclusions A process-focused, employee-involved approach to operational management can effectively identify and address problems and inefficiencies within a laboratory’s workflows. Process analysis tools facilitate a thorough analysis and a mutual understanding of the laboratory’s existing processes. The information yielded by the use of these tools is key to the team’s success in objectively assessing the current state for opportunities for improvement. Application of Lean principles effectively reduced waste within the laboratory’s processes and is proof that manufacturing- based quality improvement methods can be used to effectively improve operational efficiency and effectiveness. These process changes have yielded opportunities for improvements in related processes. The staff involved in this project have produced recommendations for other process improvements in other laboratories and work areas. Improvement projects such as this one create “momentum” for continuous improvements throughout the laboratory. Kent Becker, Jeanne Myers, Cheryl Lown, Tanika Moreland, Rose Meyer, Chad Hoffman Anatomic Pathology, Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 References 1. Madison, D. Process Mapping, Process Improvement, and Process Management: A Practical Guide to Enhancing Work and Information Flow. Chico, CA: Paton Press LLC; 2005. 2. Liker JK. The Toyota Way: 14 Management Principles from the World’s Greatest Manufacturer. New York, NY: McGraw-Hill; 2004 3. Persoon TJ, Zaleski M, Cohen M. Improving pap test turnaround time using external benchmark data and engineering process improvement tools. Anatomic Am J Clin Pathol. 2002; 118:527-533. 4. Zarbo RJ, D’Angelo R. Transforming to a quality culture: the Henry Ford Production System. Am J Clin Pathol. 2006;126(suppl 1):S21-29. Contact Information: kent- [email protected] Figures 1a,b: “As-is” process maps under development. Figure 1a was the lab’s pre-accessioning process; Figure 1b was the accessioning process. These process maps were initially constructed using a combination of self-stick notes, whiteboards, poster paper, etc. These materials made it easy to edit the details and reconfigure the process steps during construction. Figure 4. Avoid keys that force readers to labor through complicated graphs: just label all the lines (or bars) and then delete the silly key altogether (as above). The above figure would also be greatly improved if I had the ability to draw mini rats with and without brains. I would then put these really cute little illustrations next to the lines they represent. Effective Use of Process Analysis and Lean Principles to Improve Processes within the Gynecologic Cytopathology Testing Cycle Objectives Utilize a team approach and process analysis tools to thoroughly investigate the current state of the laboratory’s pre-analytical and post-analytical workflows; create a consensus understanding of these workflows. Assess the current state for whether these processes adhere to Lean principles; identify opportunities for process improvements. Streamline the existing processes by removing non-value added process steps, by standardizing the workflows, and by reducing opportunities for error. Methods Phase 1: Getting started. Meeting with management. Defined scope and established project objectives. Formation of the process improvement project team: Quality assurance representative and division manager serving as co-project facilitators; primary operators within the specimen receipt, accessioning, and preparation areas; a cytotechnologist; a financial manager. Communication of the team charter to the team members. Outlined the project objectives and scope. Provided the team with a basic introduction to process analysis, process redesign, and Lean principles. R em ove specim en and requisition from transportbag. “Roughly”prioritize the specim ens - FIFO by collection date. Indication of collection at Colposcopy? “S TA T”or Other“Urgent” R equest? Position the specim ens as a “sub-batch”atthe startorend ofa largerprep batch. Yes Assess specim en and requisition. Yes Specimen acceptable for analysis? Requisition with required information? Y es Troubleshooting. No Y es Sortout specimens requiring exceptional handling. No No (Rem aining specim ens are “R outine”) B O LO 4: · ”Endo”w ritten on the specimen · IPR requisition w here visit= “Colposcopy Clinic” · H-2 requisition w ith “colposcopy”checked or noted in the history or clinicalcomment. Specim ens expected from U IDL? WaitforUIDL specimens. No Yes UIDL received? No Label each specim en w ith its assigned pre- printed accession numberlabel. Label each specim en w ith its assigned pre- printed accession numberlabel. Place specim en in a prep rack in orderofaccession rumber. Receive a batch of12 with worksheet? Yes No Yes Label each requisition w ith its assigned pre- printed accession numberlabel. Racked batch ready forprep. P lace in prep rack in nextavailable position (1-12). W orksheet Specimens Requisitions Ready this batch forprep. Putin file holder forprep. File requisitions. VAM C vs. OtherUIDL? Other U IDL VAM C Specimens Requisitions Stack to correspond with the position (1-12) ofthe specim en in prep batch. Specimens Requisitions Stack to correspond with the position (1-12) ofthe specim en in prep batch. D o you have a batch of12 specimens? B atch of12 requisitions for accesssioning. Batch of12 specim ens forprep. Labeleach requisition w ith its assigned pre- printed accession numberlabel. No Specimens Requisitions End ofa prep batch. Yes No Cytopathology G YN Specim ens “Pre-accessioning”Process Detailed Representation GYN specim ens received in Cytopathology. Printa VA P w orksheetand slide labels. W orksheet Attach specim en requisitions to the worksheet. Putworksheetwith reqs in the file holderforprep. Attach specim en requisitions to the w orksheet. (Continue filling prep batch.) Specim ens in a prep rack as a “sub-batch”. No Conventional smear? Setaside as a batch. Specimens Requisitions Assign accession num berfrom the pre-printed list. Label the requisition(s)with a pre-printed accession num ber label – the accn numberassigned to the specim en. W rite accession num beron slide w ith pencil. Place in the slide in coplin jar containing 95% ETOH. Held atsorting bench. (to be m atched w ith w orklist – after accessioning.) Sub-batch ofrequisitions forbatch accessioning. Yes Specim ens and requisitions ready forlabeling and batch assignm ent. Labeleach specim en with the nextsequential, pre-printed accession num ber label. Place in prep rack in nextavailable position (1-12). Specimens Requisitions Stack to correspond with the position (1-12) ofthe specim en in prep batch. D o you have a batch of 12 specimens? B atch of12 requisitions for accesssioning. Batch of12 specim ens forprep. Labeleach requisition w ith the otherpre-printed accession num ber label – sam e accn num beras used to labelthe spem en. Specimens Requisitions E nd ofa prep batch. Yes No Setaside as a STAT batch. Position the specim ens as a “sub-batch”atthe startorend ofa largerprep batch. Specimens Requisitions Stack to correspond with the position (1-12) ofthe specim en in prep batch. Sub-batch ofrequisitions forbatch accessioning. Specim ens in a prep rack as a “sub-batch”. Setaside as a COLPO batch. Position the specim ens as a “sub-batch”atthe startorend ofa largerprep batch. Specimens Requisitions Stack to correspond with the position (1-12) ofthe specim en in prep batch. Specim ens in a prep rack as a “sub-batch”. Sub-batch ofrequisitions forbatch accessioning. Figure 2: Process map of the “as-is” pre-accessioning process (Figure 1a) once translated into a Visio diagram (Microsoft, Redmond, WA). This process map detailed the steps involved in specimen receipt, unpackaging, assessment and batching – steps occurring before a subsequent acccessioning process. Process mapping proved to be a key tool as it facilitated a consensus understanding and a thorough assessment of the “as-is” process. Figure 3: Example of a “5-whys” tree-diagram developed during the analysis of the “as-is” pre-accessing process map (represented in Figure 2). This tool helped the project team to understand the rationale behind certain aspects of the current process – in this case, why the work was batch accessioned and why worklists were being produced at accessioning. It also served to remind the team of key issues to consider when proposing process changes. C ases are listed in batches on w orksheets. 12 specim ens are the “bestfit”size of batch size forour automation. A “full”rack holds 12 specim ens. Instrum entrack is configured in a 4 x 3 array. Instrumentis designed to handle m ultiples of4. P rep needs the w orksheetto setup the run. P rep perform s a successive check on the specim en labeling. The run is setup in the orderlisted on the w orksheet The w orksheetis used to label tubes and slides and assign “location”. Provides a m eans to prioritize w ork. Som etim es a specim en gets m islabeled at accessioning. “C lerical errors occasionally happen.” Positioning of specim en,tubes, and slides m ust correspond. C olpos and “stats” are m oved to the frontofthe line. Im proves TAT of these specim ens.. C T’s use the w orksheetto highlightcases. H ighlightcases for secondary review . H ighlightcases for teaching and Q .C . reasons. C ase m eets criteria for secondary review . Regulatory m andates. Teaching, concordance evals.,etc Facilitates correlation w ith histology. W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? W hy? Methods (cont.) Investigation and measurements of specimens held in waiting because accessioning workstations could not accession concurrently. Defined the customers of these processes and identified their requirements. Phase 3: Process redesign and trials. The team collectively developed first-cut redesigns of the process maps. The information assembled during Phase 2 was crucial in developing proposed process changes. The diverse experience and collective expertise of the project team members facilitated a rapid feasibility assessment of proposed changes. The redesigned processes were trialed for feasibility. Some minor adjustments were necessary to make the redesigned processes operationally feasible, but the Lean principles driving the changes remained. Phase 4: Implementation of redesign. Finalized the redesigns; revised the process maps; revised procedures. Changes to the information system trialed in Phase 3 were moved from the system’s test environment to the production environment. Trained affected personnel on procedural changes. Implemented measures to prevent reversion: Information system changes (by rule) prevented reversion. Removed the supplies made obsolete by the process redesigns. Monitored occurrence reports for any problems with the redesigned processes. Figure 4: Examples of some of the steps and decision trees found in the “as-is” process maps. Each step (or a combination of steps) of the “as-is” process map could be evaluated for deviation from Lean principles. Chart 1: Breakdown of a sampling of specimen wait times in Outreach. Elapsed time was measured from time of receipt to time accessioned. (N=49) Table 1: Measurement of the “wait effect”. Cytopathology could not begin accessioning specimens until outreach had completed their specimens. Results Pre-accessioning process after redesign: Process for pre-analytical technical billing entry: Process for post-analytical professional billing: Figure 5: The final version of the pre-accessioning process map after process redesign and feasibility trial. For comparison, Figure 2 is the corresponding before map. Redesign removed 8 decision steps and 32 action steps – reductions of 73% and 86% respectively. R eports atprinter TA08. D oes report indicate Pathologist review? No N o professionalbilling. S hred report. Y es TP28 C Y28 D etermine the procedure code mnemonic to be entered forthe professional billing. TP28 or C Y 28 O rderC Y28-P Foreach procedure listed, determ ine w hether a GC m odifier needs to be added. P lace reportin folderand hold. W aitforMSA charge processing to run. (daily at18:00?) Logon to Inform m M SA processing ofthe procedures cannotbe perform ed untilthe charges have crossed from C ernerto Informm . MSA = Medical S ervice A dministration, i.e.physician charges Is there indication of fellow or resident involvement? SelectP R O C ES S LAB M SA CHARGES S electC -Y Y- ##### to process GYN cytology case charges. Informm displays the listofC -cases with charges pending MSA processing. E nter“A”atthe S election ==> (___)prompt. Type the line numberdisplayed nextto the case # to be processed. C ursormoves to “NO C olumn” Getthe case num berfrom the report. R eview the procedures listed forthe case. Yes,acceptG C . N o,rem ove G C. E nterthe line# of the procedure, Informm displays the case specific procedures with charges pending MSA processing. IPR rem oves the G C forthe procedure on that line and indicates a “1”in the N O colum n. R eview for accuracy. C hange(s) needed? P rocess next case? S hred the case report. Y es No No O rderTP 28-P G YN specim ens received in C ytopathology. R em ove specim en and requisition from transportbag. “R oughly”prioritize the specim ens - FIFO by collection date. Assess specim en and requisition. Specimen acceptable for analysis? Requisition w ith required inform ation? Yes Troubleshooting. No No C an problem be rem edied? Specim en and requisition ready foraccessioning. Yes Yes N o,testing cannotbe perform ed. Apply rem edy. Yes C ancel G YN w ith order footnote explanation of reason forrejection. Accession as GYN. Liquid-based C onventional sm ear O rderC Y 28 O rderTP28 Ataccessioning,a procedure m nem onic is entered forthe technical billing. See A ccessioning Process forG YN Specim ens. Liquid-based or C onventional sm ear? D eterm ine type of collection Screening or D iagnostic? Screening or D iagnostic? Liquid-based C onventional sm ear S creening O rderTP27 O rderC Y27 O rderC Y28 O rderTP28 D iagnostic Screening D iagnostic From the Free M edical C linic? Yes No Ataccessioning,a procedure m nem onic is entered forthe technical billing. See A ccessioning P rocess forG YN Specim ens. Liquid-based or C onventional sm ear? D eterm ine type of collection O rderC Y00 R eports atprinter TA08. D oes report indicate P athologist review? No N o professional billing. S hred report. Yes N egative or Abnormal? CY27 or CY28 TP 27/28 C Y27/28 Negative Abnorm al CY27 CY28 TP27 or TP28 TP27 TP28 D etermine the procedure code mnemonic to be entered forthe professional billing. TP 27/28 or C Y27/28 N egative or Abnorm al? Negative A bnorm al N egative or Abnormal? Negative Abnorm al N egative or Abnormal? Negative Abnorm al O rderCLIA O rderTP27-P CLIA O rderTP28-P O rderCLIA O rderCY27-P O rderCLIA O rderCY28-P Foreach procedure listed, determine w hether a GC modifier needs to be added. P lace reportin folderand hold. W aitforMSA charge processing to run. (daily at18:00?) Logon to Informm MS A processing ofthe procedures cannotbe performed until the charges have crossed from Cernerto Inform m. MSA = Medical S ervice Administration, i.e.physician charges Is there indication of fellow or resident involvement? S electP R O C E SS LAB MSA CHARGES S electC-YY- ##### to process GY N cytology case charges. Informm displays the listofC-cases with charges pending MSA processing. E nter“A”atthe Selection ==> (___)prompt. Type the line numberdisplayed nextto the case # to be processed. C ursormoves to “N O C olumn” Getthe case numberfrom the report. R eview the procedures listed forthe case. Yes,acceptG C . N o,remove GC. E nterthe line# of the procedure, Informm displays the case specific procedures with charges pending MS A processing. IP R removes the GC forthe procedure on that line and indicates a “1”in the N O column. R eview for accuracy. C hange(s) needed? Process next case? Shred the case report. Y es No No Before: 7 decision steps; 5 different billing codes. After: 2 decision steps; 2 different billing codes. Before: 4 decision steps; Select from 5 billing codes After: 1 decision step; Select from 2 billing codes Results B efore A fter % R eduction Process Decision Action Decision Action Decision Action O verall Pre-accessioning 11 37 3 5 -73% -86% -83% A ccessioning 23 70 22 55 -4% -21% -17% TechnicalB illing 4 6 1 3 -75% -50% -60% ProfessionalB illing 11 25 5 19 -55% -24% -33% Totals 49 138 31 82 -37% -41% -40% 0 2 4 6 8 10 12 14 16 18 20 1-2 hrs >2-4 hrs >4-8 hrs N um b er o fS pecim en Sum m ary ofProcess Im provem ents B efore A fter • Specim ens accessioned in batches. • Single piece flow . • Push system -Excess supply ofpre- produced labels enables labeling errors. • Pull system -Labels printed by LIS on dem and ataccn# assignm ent– no excess supply ofpreprinted accn#’s. • W orklists w ere produced in excess and priorto w hen they w ere needed. • W orklists are produced justpriorto utilization. • Specim ens w ere pre-labeled w ith accn# priorto accessioning – disconnected from accn# assignm entby LIS. • Labeling occurs im m ediately afteraccn# is assigned by the LIS – system atic m eans to reduce labeling error. • N o patientidentifiers on the accn# labels. • Labels include accn# and patient identifiers. • Labeling w as inconsistentbetw een w orkstations. • Specim ens accessioned atthe outreach w orkstation had to be re-labeled upon receiptin C ytopathology. • Labeling is standardized betw een w orkstations. • N o re-labeling;no rew ork;rem oved an “opportunity”forlabeling error. • Bottlenecks & delays because workstations could notaccession concurrently. • W orkflow m anagem entw as inflexible – the process im posed lim itations atthe startand end ofeach day. • C oncurrentaccessioning enabled; bottlenecks & delays alleviated. • W ith constraints on w orkflow s rem oved, production is flexible. Accessioning can occurthroughoutthe day,every day. • O verly com plex pre-accessioning process. • Procedure docum entation w as poor; • Process notuniversally understood. • D ifficultto troubleshootvariances from expected outcom es. • Stream lined and standardized. • Procedural docum entation vetted and validated by underlying process m aps;a consensus understanding exists. • Pinpointidentification ofthe specific process step thatfailed. • O verly com plex decision trees in billing processes;doesn’tadd value. • Stream lined to rem ove redundancies, and non-value added com plexities. Tim e offirst accession. D ay 1 09:20 D ay 2 09:56 D ay 3 09:23 D ay 4 09:48 WaitforUIDL specim ens. D elays. Setaside as a batch. “U n-Level” Pre-labeleach specim en w ith the nextsequential, pre-printed accession num ber label. CO E accession m atch label on requisition? Troubleshooting!!! No Assign the specim en an accession num ber from the pre- printed list. Excess inventory. Push system . Lack of synchronization enables defects. Labeling accuracy is w holly dependenton hum an diligence. N egative or Abnormal? CY27 or CY28 TP27/28 C Y27/28 Negative Abnorm al CY27 CY28 TP27 or TP28 TP27 TP28 TP27/28 or C Y27/28 N egative or Abnormal? Negative Abnorm al N egative or Abnormal? Negative Abnorm al N egative or Abnormal? Negative Abnorm al O verprocessing. Com plex processes that do notadd value to the product.

Transcript of Abstract Staff members of the Department of Pathology, University of Iowa Hospitals and Clinics set...

  • Slide 1

Abstract Staff members of the Department of Pathology, University of Iowa Hospitals and Clinics set forth to redesign and improve the pre- analytical and post-analytical process phases of the gynecologic cytopathology testing cycle through the utilization of process analysis tools and the application of Lean methodology. The project team developed detailed process maps and why-why tree diagrams of the reasoning for certain steps or constraints within the current process. These process analysis tools effectively served to establish a common understanding of the current process. The team was then able to thoroughly assess the current process for deviations from Lean principles and identified various sources of waste and process defects. Process redesigns were drafted and trialed for feasibility prior to implementation. The redesigns effectively reduced the total number of steps within these processes by 40% versus the number of steps being performed at project inception. The redesigns applied to gynecologic specimen receipt and accessioning processes: 1) effectively transformed the process from a batch-and-queue workflow to single piece flow, 2) eliminated a significant process constraint, and 3) provided a systematic means for reducing specimen labeling errors. The teams assessments also identified inefficiencies in billing processes that were eliminated by process redesign. Overall, the teams improvement project demonstrated that a process- focused analysis governed by the application of Lean principles can effectively improve laboratory operations, reduce the potential for error, and identify many other opportunities for improvements in tangential processes. Background The Cytopathology Laboratory receives and accessions roughly 18,000 gynecologic cytology specimens annually. A lack of a consensus understanding of the current workflows and the relevant history that lead to the current state created frustrations. Consequently, it was difficult to manage this area. Ultimately, management decided the pre and post analytical workflows of this laboratory were prime candidates for a formalized process improvement project. Methods (cont.) Phase 2: As-is process analysis and measurements. Process mapping the current processes. ( Figures 1a,b & 2 ). Process maps were developed by directly observing the primary operators performing the current processes. The process maps established a baseline representation and facilitated a common understanding of the current state. Use of the 5-Whys tool to analyze key features of the process ( Figure 3 ) Enabled thorough analysis and effectively identified the reasoning and root causes behind the current state. Identification of process steps contrary to Lean principles. Conclusions A process-focused, employee-involved approach to operational management can effectively identify and address problems and inefficiencies within a laboratorys workflows. Process analysis tools facilitate a thorough analysis and a mutual understanding of the laboratorys existing processes. The information yielded by the use of these tools is key to the teams success in objectively assessing the current state for opportunities for improvement. Application of Lean principles effectively reduced waste within the laboratorys processes and is proof that manufacturing-based quality improvement methods can be used to effectively improve operational efficiency and effectiveness. These process changes have yielded opportunities for improvements in related processes. The staff involved in this project have produced recommendations for other process improvements in other laboratories and work areas. Improvement projects such as this one create momentum for continuous improvements throughout the laboratory. Kent Becker, Jeanne Myers, Cheryl Lown, Tanika Moreland, Rose Meyer, Chad Hoffman Anatomic Pathology, Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 References 1.Madison, D. Process Mapping, Process Improvement, and Process Management: A Practical Guide to Enhancing Work and Information Flow. Chico, CA: Paton Press LLC; 2005. 2.Liker JK. The Toyota Way: 14 Management Principles from the Worlds Greatest Manufacturer. New York, NY: McGraw-Hill; 2004 3.Persoon TJ, Zaleski M, Cohen M. Improving pap test turnaround time using external benchmark data and engineering process improvement tools. Anatomic Am J Clin Pathol. 2002; 118:527-533. 4.Zarbo RJ, DAngelo R. Transforming to a quality culture: the Henry Ford Production System. Am J Clin Pathol. 2006;126(suppl 1):S21-29. Contact Information: [email protected] Figures 1a,b: As-is process maps under development. Figure 1a was the labs pre- accessioning process; Figure 1b was the accessioning process. These process maps were initially constructed using a combination of self-stick notes, whiteboards, poster paper, etc. These materials made it easy to edit the details and reconfigure the process steps during construction. Figure 4. Avoid keys that force readers to labor through complicated graphs: just label all the lines (or bars) and then delete the silly key altogether (as above). The above figure would also be greatly improved if I had the ability to draw mini rats with and without brains. I would then put these really cute little illustrations next to the lines they represent. Effective Use of Process Analysis and Lean Principles to Improve Processes within the Gynecologic Cytopathology Testing Cycle Objectives Utilize a team approach and process analysis tools to thoroughly investigate the current state of the laboratorys pre- analytical and post-analytical workflows; create a consensus understanding of these workflows. Assess the current state for whether these processes adhere to Lean principles; identify opportunities for process improvements. Streamline the existing processes by removing non-value added process steps, by standardizing the workflows, and by reducing opportunities for error. Methods Phase 1: Getting started. Meeting with management. Defined scope and established project objectives. Formation of the process improvement project team: Quality assurance representative and division manager serving as co-project facilitators; primary operators within the specimen receipt, accessioning, and preparation areas; a cytotechnologist; a financial manager. Communication of the team charter to the team members. Outlined the project objectives and scope. Provided the team with a basic introduction to process analysis, process redesign, and Lean principles. Figure 2: Process map of the as-is pre-accessioning process (Figure 1a) once translated into a Visio diagram (Microsoft, Redmond, WA). This process map detailed the steps involved in specimen receipt, unpackaging, assessment and batching steps occurring before a subsequent acccessioning process. Process mapping proved to be a key tool as it facilitated a consensus understanding and a thorough assessment of the as-is process. Figure 3: Example of a 5-whys tree-diagram developed during the analysis of the as-is pre-accessing process map (represented in Figure 2). This tool helped the project team to understand the rationale behind certain aspects of the current process in this case, why the work was batch accessioned and why worklists were being produced at accessioning. It also served to remind the team of key issues to consider when proposing process changes. Methods (cont.) Investigation and measurements of specimens held in waiting because accessioning workstations could not accession concurrently. Defined the customers of these processes and identified their requirements. Phase 3: Process redesign and trials. The team collectively developed first-cut redesigns of the process maps. The information assembled during Phase 2 was crucial in developing proposed process changes. The diverse experience and collective expertise of the project team members facilitated a rapid feasibility assessment of proposed changes. The redesigned processes were trialed for feasibility. Some minor adjustments were necessary to make the redesigned processes operationally feasible, but the Lean principles driving the changes remained. Phase 4: Implementation of redesign. Finalized the redesigns; revised the process maps; revised procedures. Changes to the information system trialed in Phase 3 were moved from the systems test environment to the production environment. Trained affected personnel on procedural changes. Implemented measures to prevent reversion: Information system changes (by rule) prevented reversion. Removed the supplies made obsolete by the process redesigns. Monitored occurrence reports for any problems with the redesigned processes. Figure 4: Examples of some of the steps and decision trees found in the as-is process maps. Each step (or a combination of steps) of the as-is process map could be evaluated for deviation from Lean principles. Chart 1 : Breakdown of a sampling of specimen wait times in Outreach. Elapsed time was measured from time of receipt to time accessioned. (N=49) Table 1: Measurement of the wait effect. Cytopathology could not begin accessioning specimens until outreach had completed their specimens. Results Pre-accessioning process after redesign: Process for pre-analytical technical billing entry: Process for post-analytical professional billing: Figure 5: The final version of the pre-accessioning process map after process redesign and feasibility trial. For comparison, Figure 2 is the corresponding before map. Redesign removed 8 decision steps and 32 action steps reductions of 73% and 86% respectively. Before: 7 decision steps; 5 different billing codes. After: 2 decision steps; 2 different billing codes. Before: 4 decision steps; Select from 5 billing codes After: 1 decision step; Select from 2 billing codes Results